Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 20c; Bumps Guidance Higher
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/21/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- Fed: Nine Of 18 FOMC Participants Pencil In 2026 Rate Hike
- Delta Air Lines (DAL) Raises Quarterly Dividend 14.7% to $0.2150; 1% Yield
- Oil rises 1% on US-Iran deal doubts; IEA warns of supply glut
Zimmer Biomet Announces First Quarter 2022 Financial Results
May 3, 2022 6:30 AM EDTFirst quarter net sales from continuing operations of $1.663 billion increased 3.9% and 6.8% on a constant currency1 basis First quarter diluted earnings per share from continuing operations were $0.35; adjusted1 diluted earnings per share from continuing operations were $1.61 Company updates 2022 financial guidance, raising and tightening range for full year outlook Completed the spinoff of ZimVie Inc. on March 1, 2022
WARSAW, Ind., May 3, 2022 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended March 31, 2022. The Company reported first quarter net sales from continuing operations of... More
